Litcius/Paper detail

Ponatinib and blinatumomab for Philadelphia chromosome-positive acute lymphoblastic leukaemia: a US, single-centre, single-arm, phase 2 trial

Elias Jabbour, Nicholas J. Short, Nitin Jain, Xuelin Huang, Guillermo Montalban‐Bravo, Pinaki P. Banerjee, Katayoun Rezvani, Xianli Jiang, Kun Hee Kim, Rashmi Kanagal‐Shamanna, Joseph D. Khoury, Keyur P. Patel, Tapan M. Kadia, Naval Daver, Kelly S. Chien, Yesid Alvarado, Guillermo Garcia‐Manero, Ghayas C. Issa, Fadi Haddad, Monica Kwari, Jennifer Thankachan, Ricardo Delumpa, Walid Macaron, Rebecca Garris, Marina Konopleva, Farhad Ravandi, Hagop M. Kantarjian

2022The Lancet Haematology239 citationsDOI

Topics & Concepts

MedicinePonatinibBlinatumomabPhiladelphia chromosomeLymphoblastic LeukemiaInternal medicineOncologyPediatricsLeukemiaDasatinibChromosomal translocationGeneticsMyeloid leukemiaImatinibGeneBiologyAcute Lymphoblastic Leukemia researchChronic Myeloid Leukemia TreatmentsCAR-T cell therapy research